http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 09 Jun 2026 06:15:12 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Equity+Offerings/Novanta+announces+%24300+million+private+placement+to+institutional+investors/26619851.html <p>Novanta Inc. entered into a securities purchase agreement for a private placement expected to generate approximately $300 million in gross proceeds before fees and expenses, the company announced.</p> <p>Under the agreement, institutional and accredited investors will purchase 2,142,857 common shares at $140.00 per share. The private placement is scheduled to close on or about June 11, 2026, subject to customary closing conditions.</p> <p>The shares are being sold in a transaction not involving a public offering and have not been registered under the Securities Act of 1933. The shares may not be reoffered or resold in the United States except through an effective http://www.streetinsider.com/Equity+Offerings/Novanta+announces+%24300+million+private+placement+to+institutional+investors/26619851.html Tue, 09 Jun 2026 06:15:12 -0400 NOVT O.01845926 http://www.streetinsider.com/Equity+Offerings/Novanta+announces+%24300+million+private+placement+to+institutional+investors/26619851.html <p>Novanta Inc. entered into a securities purchase agreement for a private placement expected to generate approximately $300 million in gross proceeds before fees and expenses, the company announced.</p> <p>Under the agreement, institutional and accredited investors will purchase 2,142,857 common shares at $140.00 per share. The private placement is scheduled to close on or about June 11, 2026, subject to customary closing conditions.</p> <p>The shares are being sold in a transaction not involving a public offering and have not been registered under the Securities Act of 1933. The shares may not be reoffered or resold in the United States except through an effective http://www.streetinsider.com/Equity+Offerings/Novanta+announces+%24300+million+private+placement+to+institutional+investors/26619851.html Tue, 09 Jun 2026 06:15:12 -0400 NOVT O.01845926 http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+%24300+Million+Private+Placement/26619849.html <p> BOSTON--(BUSINESS WIRE)-- Novanta Inc. ("Novanta" or the “Company”) announced today that it has entered into a securities purchase agreement for a private placement of the Company’s common shares (“Common Shares”) to institutional and other accredited investors that is expected to result in gross proceeds of approximately $300 million to the Company, before placement agent fees and offering expenses. </p><p> Pursuant to the terms of the securities purchase agreement, the investors agreed to purchase an aggregate of 2,142,857 Common Shares at a purchase price of $140.00 per share. The private placement is expected to close on or about June 11, http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+%24300+Million+Private+Placement/26619849.html Tue, 09 Jun 2026 06:15:00 -0400 NOVT O.01845926 http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+%24300+Million+Private+Placement/26619849.html <p> BOSTON--(BUSINESS WIRE)-- Novanta Inc. ("Novanta" or the “Company”) announced today that it has entered into a securities purchase agreement for a private placement of the Company’s common shares (“Common Shares”) to institutional and other accredited investors that is expected to result in gross proceeds of approximately $300 million to the Company, before placement agent fees and offering expenses. </p><p> Pursuant to the terms of the securities purchase agreement, the investors agreed to purchase an aggregate of 2,142,857 Common Shares at a purchase price of $140.00 per share. The private placement is expected to close on or about June 11, http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+%24300+Million+Private+Placement/26619849.html Tue, 09 Jun 2026 06:15:00 -0400 NOVT O.01845926 http://www.streetinsider.com/Business+Wire/Novanta+Inc.+Announces+%24300+Million+Private+Placement/26619849.html <p> BOSTON--(BUSINESS WIRE)-- Novanta Inc. ("Novanta" or the “Company”) announced today that it has entered into a securities purchase agreement for a private placement of the Company’s common shares (“Common Shares”) to institutional and other accredited investors that is expected to result in gross proceeds of approximately $300 million to the Company, before placement agent fees and offering expenses. </p><p> Pursuant to the terms of the securities purchase agreement, the investors agreed to purchase an aggregate of 2,142,857 Common Shares at a purchase price of $140.00 per share. The private placement is expected to close on or about June 11, http://www.streetinsider.com/Business+Wire/Novanta+Inc.+Announces+%24300+Million+Private+Placement/26619849.html Tue, 09 Jun 2026 06:15:00 -0400 NOVT O.01845926 http://www.streetinsider.com/Business+Wire/Novanta+Inc.+Announces+%24300+Million+Private+Placement/26619849.html <p> BOSTON--(BUSINESS WIRE)-- Novanta Inc. ("Novanta" or the “Company”) announced today that it has entered into a securities purchase agreement for a private placement of the Company’s common shares (“Common Shares”) to institutional and other accredited investors that is expected to result in gross proceeds of approximately $300 million to the Company, before placement agent fees and offering expenses. </p><p> Pursuant to the terms of the securities purchase agreement, the investors agreed to purchase an aggregate of 2,142,857 Common Shares at a purchase price of $140.00 per share. The private placement is expected to close on or about June 11, http://www.streetinsider.com/Business+Wire/Novanta+Inc.+Announces+%24300+Million+Private+Placement/26619849.html Tue, 09 Jun 2026 06:15:00 -0400 NOVT O.01845926 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NOVANTA+INC+++++++++++++++For%3A+Jun+08/26619795.html si-local-file:///var/storage/secattach/20260609/26619795.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NOVANTA+INC+++++++++++++++For%3A+Jun+08/26619795.html Tue, 09 Jun 2026 06:05:00 -0400 NOVT NOVTU O.01845926 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NOVANTA+INC+++++++++++++++For%3A+Jun+08/26619795.html si-local-file:///var/storage/secattach/20260609/26619795.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NOVANTA+INC+++++++++++++++For%3A+Jun+08/26619795.html Tue, 09 Jun 2026 06:05:00 -0400 NOVT NOVTU O.01845926 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NOVANTA+INC+++++++++++++++For%3A+Jun+08/26619795.html si-local-file:///var/storage/secattach/20260609/26619795.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NOVANTA+INC+++++++++++++++For%3A+Jun+08/26619795.html Tue, 09 Jun 2026 06:05:00 -0400 NOVT NOVTU O.01845926 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html <p>Novanta Inc. (NASDAQ: NOVT) announced it has entered into a definitive agreement to acquire Riverpoint Medical, a manufacturer of minimally invasive surgical consumables, for $1.2 billion in upfront cash plus a $250 million milestone payment in the first quarter of 2027.</p> <p>The transaction, expected to close in the third quarter of 2026 subject to regulatory approvals, will acquire Riverpoint Medical from Arlington Capital Partners. Riverpoint develops medical devices focused on surgical fibers and related technologies for sports medicine, trauma and cardiovascular surgery markets.</p> <p>"Riverpoint Medical is growing revenue and cash flows at twice the rate of Novanta, with an expected long-term annual http://www.streetinsider.com/Mergers+and+Acquisitions/Novanta+to+acquire+Riverpoint+Medical+for+%241.2+billion/26619506.html Tue, 09 Jun 2026 06:00:22 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+Acquisition+of+Riverpoint+Medical/26619476.html <ul class="bwlistdisc"> <li> <b>Accelerates Novanta’s strategic direction, expands portfolio into high-growth minimally invasive surgery segment, and doubles recurring medical consumables revenue</b> </li> <li> <b>Transaction is immediately accretive to Novanta’s revenue growth, Adjusted Gross and EBITDA margins, Adjusted Diluted EPS, and Operating Cash Flows</b> </li> </ul> <p> BOSTON--(BUSINESS WIRE)-- Novanta Inc. (NASDAQ: NOVT) (“Novanta” or the “Company”), a trusted technology partner to leading global medical and industrial original equipment manufacturers (OEMs), today announced that it has entered into a definitive agreement to acquire Riverpoint Medical (“Riverpoint Medical” or “Riverpoint”), a category leader in high-growth minimally invasive surgical consumables, from Arlington Capital Partners (“Arlington”), a Washington D.C.-area private http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+Acquisition+of+Riverpoint+Medical/26619476.html Tue, 09 Jun 2026 06:00:00 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+Acquisition+of+Riverpoint+Medical/26619476.html <ul class="bwlistdisc"> <li> <b>Accelerates Novanta’s strategic direction, expands portfolio into high-growth minimally invasive surgery segment, and doubles recurring medical consumables revenue</b> </li> <li> <b>Transaction is immediately accretive to Novanta’s revenue growth, Adjusted Gross and EBITDA margins, Adjusted Diluted EPS, and Operating Cash Flows</b> </li> </ul> <p> BOSTON--(BUSINESS WIRE)-- Novanta Inc. (NASDAQ: NOVT) (“Novanta” or the “Company”), a trusted technology partner to leading global medical and industrial original equipment manufacturers (OEMs), today announced that it has entered into a definitive agreement to acquire Riverpoint Medical (“Riverpoint Medical” or “Riverpoint”), a category leader in high-growth minimally invasive surgical consumables, from Arlington Capital Partners (“Arlington”), a Washington D.C.-area private http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+Acquisition+of+Riverpoint+Medical/26619476.html Tue, 09 Jun 2026 06:00:00 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+Acquisition+of+Riverpoint+Medical/26619476.html <ul class="bwlistdisc"> <li> <b>Accelerates Novanta’s strategic direction, expands portfolio into high-growth minimally invasive surgery segment, and doubles recurring medical consumables revenue</b> </li> <li> <b>Transaction is immediately accretive to Novanta’s revenue growth, Adjusted Gross and EBITDA margins, Adjusted Diluted EPS, and Operating Cash Flows</b> </li> </ul> <p> BOSTON--(BUSINESS WIRE)-- Novanta Inc. (NASDAQ: NOVT) (“Novanta” or the “Company”), a trusted technology partner to leading global medical and industrial original equipment manufacturers (OEMs), today announced that it has entered into a definitive agreement to acquire Riverpoint Medical (“Riverpoint Medical” or “Riverpoint”), a category leader in high-growth minimally invasive surgical consumables, from Arlington Capital Partners (“Arlington”), a Washington D.C.-area private http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+Acquisition+of+Riverpoint+Medical/26619476.html Tue, 09 Jun 2026 06:00:00 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512 http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+Acquisition+of+Riverpoint+Medical/26619476.html <ul class="bwlistdisc"> <li> <b>Accelerates Novanta’s strategic direction, expands portfolio into high-growth minimally invasive surgery segment, and doubles recurring medical consumables revenue</b> </li> <li> <b>Transaction is immediately accretive to Novanta’s revenue growth, Adjusted Gross and EBITDA margins, Adjusted Diluted EPS, and Operating Cash Flows</b> </li> </ul> <p> BOSTON--(BUSINESS WIRE)-- Novanta Inc. (NASDAQ: NOVT) (“Novanta” or the “Company”), a trusted technology partner to leading global medical and industrial original equipment manufacturers (OEMs), today announced that it has entered into a definitive agreement to acquire Riverpoint Medical (“Riverpoint Medical” or “Riverpoint”), a category leader in high-growth minimally invasive surgical consumables, from Arlington Capital Partners (“Arlington”), a Washington D.C.-area private http://www.streetinsider.com/Press+Releases/Novanta+Inc.+Announces+Acquisition+of+Riverpoint+Medical/26619476.html Tue, 09 Jun 2026 06:00:00 -0400 A.05453562 A.10707735 A.15776824 A.17839596 A.35610619 NOVT O.00042518 O.00046809 O.00046810 O.00075773 O.01845926 O.51342512